Cano Health

Cano Health, Inc. operates primary care centers and supports affiliated medical practices that engages in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico. It provides population health management tools including telehealth, prescription home delivery, wellness programs, transition of care, and high-risk and complex care management. The company was founded by Marlow Hernandez in 2009 and is headquartered in Miami, FL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Cano Health reports strong 2022 performance, eyes growth opportunities

Cano Health demonstrated strong performance in membership growth and revenue generation in 2022, despite facing challenges in revenue per member and goodwill impairment. Strategic actions to enhance liquidity and operational efficiency position the company for future growth.
The company's focus on optimizing operations, expanding strategically, and improving cash flows presents opportunities for sustainable growth and profitability. Renegotiated contracts and cost-saving initiatives aim to address challenges and drive financial performance.
With a clear roadmap for 2023, including membership and revenue targets, Cano Health is poised to capitalize on its strengths, navigate challenges, and leverage opportunities to drive value for stakeholders. The company's financial health and growth prospects remain promising.

Cano Health reports robust Q1 performance, focuses on profitability

Cano Health's Q1 2023 performance showcased strong revenue growth, membership expansion, and a focus on operational efficiency and profitability.
The company faces challenges in managing increased MCR and seasonality impacts but is strategically positioned to capitalize on opportunities for growth and cost optimization.
By divesting non-core assets, reallocating resources, and focusing on Medicare Advantage business, Cano Health aims to drive profitability and enhance shareholder value.
Overall, Cano Health's performance, strategic initiatives, and financial position indicate a positive outlook for continued growth and operational improvements.

Cano Health reports revenue growth but faces financial challenges in Q2 2023

Cano Health's Q2 2023 showcased revenue growth and membership expansion, but challenges with financial performance and liquidity require strategic focus.
The company's strengths in core markets and operational efficiency initiatives offer opportunities for growth and improved profitability.
Navigating challenges with Medicare Risk Adjustment, unexpected expenses, and market exits will be crucial for Cano Health's future success and financial stability.

Cano Health reports Q3 losses, focuses on cost management strategies

Cano Health's Q3 2023 performance reflects a mix of challenges and strengths, with a focus on cost management and operational efficiency.
The company's strategic initiatives in the Medicare Advantage business show promise for revenue growth and cost reductions.
While facing liquidity concerns and financial losses, Cano Health is actively addressing these challenges through restructuring and cost-saving measures.
Opportunities for growth and improved financial performance exist through further cost optimization and strategic decision-making.

Cano Petroleum, Inc. operates as an independent oil and natural gas company. The company was founded by Jeffery S. Johnson in 1997 and is headquartered in Tulsa, OK.

Revenue loss and a recent sell-off confirm that Cano Health stock may be struggling right now but a membership-focused strategy could help them recover.

Can Cano Health Recover From the Recent Sell-Off?

Concerns about the company's liquidity may be driving some investors away.

Why Shares of Cano Health Are Slumping This Week

Cano Health (NYSE: CANO ) stock is falling hard on Thursday following news that billionaire investor Dan Loeb has given up on the company. Loeb, head of the activist investor firm Third Point, has reportedly sold his entire stake in the company.

Billionaire Dan Loeb Just Gave Up on Cano Health (CANO) Stock

Lowered guidance and big third-quarter losses worried investors.

Why Cano Health's Shares Dropped 46.9% in November

BlackBerry

Bed Bath & Beyond

Canopy Growth

Cronos Group

Eos Energy Enterprises

Globalstar

Poseida Therapeutics

Virgin Galactic

Alaunos Therapeutics

Penny stocks with unusual options activity; are they a buy or should you avoid them entirely? The post 10 Top Penny Stocks To Watch With Unusual Options Activity Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Top Penny Stocks To Watch With Unusual Options Activity Now

Penny stocks with unusual options activity. The post 7 Penny Stocks To Watch With Unusual Options Activity, December 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Penny Stocks To Watch With Unusual Options Activity, December 2022

Cano Health, Inc. arguably has the most asymmetrical risk/reward profile we have encountered in over 20 years of managing hedge fund capital and personal wealth. The company is a leader in one of the hottest M&A markets, with potential buyers far outnumbering a dwindling list of sellers.

Cano Health: An Unappreciated Gem And Potential 10-Bagger

The value-based healthcare insurer is seen as a potential buyout candidate.

Why Shares of Cano Health Plummeted 29.5% This Week

Underwhelming Q3 earnings and 2022 guidance driven by lower PMPMs should recover heading into 2023 and beyond. DCF modeling a conservative and realistic path to profitability for Cano and prosperity for investors.

Cano Health: 75% Off Sale

Cano Health, Inc. (NYSE:CANO ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Company Participants Marlow Hernandez - Chairman and Chief Executive Officer Brian Koppy - Chief Financial Officer Conference Call Participants Andrew Mok - UBS Adam Ron - Bank of America Brian Tanquilut - Jefferies Jason Cassorla - Citibank Josh Raskin - Nephron Research Operator Good afternoon, and welcome to Cano Health's Third Quarter 2022 Earnings Call. Currently, all participants are in a listen-only mode.

Cano Health, Inc. (CANO) Q3 2022 Earnings Call Transcript

Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 75% and 6.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Cano Health, Inc. (CANO) Reports Q3 Loss, Lags Revenue Estimates

MIAMI , Nov. 9, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, today announced financial results for the third quarter ended September 30, 2022. Third Quarter Financial Results Total membership of 294,596, including 168,346 Medicare capitated members, an increase of 40% year-over-year for both Total revenue of $665.0 million, an increase of 33% year-over-year Net loss of $(112.0) million, unfavorably impacted by a $65.7 million fair value adjustment of warrant liabilities Adjusted EBITDA1 of $42.5 million, compared to $13.6 million in the third quarter of 2021, an increase of 211% year over year The Company continues to demonstrate financial and operational improvement year-over-year, with higher revenue, an improved medical cost ratio2, or MCR, and a higher Adjusted EBITDA margin.

Cano Health Announces Financial Results for the Third Quarter 2022

ACM Research

Akouos

Biohaven Pharmaceutical Hld

FingerMotion

Immunovant Inc

Ngm Biopharmaceuticals Inc

Nutex Health Inc

Tango Therapeutics

TuSimple Holdings

Small-cap stocks can offer big returns in a short period of time, especially when the economy is rebounding from a slowdown.

These Were the Five Best and Worst Performing Small-cap Stocks in October 2022

Third Point's Daniel Loeb (Trades, Portfolio) disclosed earlier this week he reduced his firm's stake in Cano Health Inc. ( CANO , Financial) by 26.1% as the stock continues to decline this month.

Daniel Loeb Curbs Cano Health Stake as Shares Slide

Third Point LLC said Tuesday in a 13D/A form with the SEC that it sold about a quarter of its Cano Health (US:CANO) stake.

Dan Loeb's Third Point LLC cuts stake in Cano Health, Inc. (CANO)

MIAMI , Oct. 26, 2022 /PRNewswire/ -- Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO), a leading value-based primary care provider and population health company, will host a conference call on Wednesday, November 9, 2022, at 5:00 PM Eastern Time to review the Company's business and financial results for the third quarter ended September 30, 2022. A press release with the results will be issued prior to the call.

Cano Health to Announce Third Quarter 2022 Results

Cano (NYSE: CANO ) stock is on the move on Tuesday after reports spread claiming the acquisition deal with CVS Health (NYSE: CVS ) is off. According to these reports, CVS is no longer moving forward with plans to acquire the Florida-based primary care provider.

CANO Stock Jumps Despite Rumors CVS Is Walking Away From Cano Health Acquisition

AMC Entertainment

Altice USA

Cricut

Eve Holding Inc

Getty Images Holdings Inc

IVERIC bio Inc

NCR Corporation

Revance Therapeutics

Sotera Health

Mid-cap stocks are a good choice for investors who are okay with relatively more volatility to get some extra returns.

These Were The Five Best And Worst Performing Mid-Cap Stocks In September 2022

CVS Health

A report says CVS has decided against pursuing a deal with Cano Health.

CVS Won't Comment on Report It's Abandoning Purchase of Cano Health

Shares of Cano Health climbed on Friday following a report the value-based primary care provider is in exclusive talks to be bought by CVS Health. The Miami-based healthcare provider went public in June 2021.

CVS in exclusive talks to acquire Cano Health: report

Health solutions company CVS Health is reportedly considering purchasing primary healthcare provider Cano Health. CVS is doing due diligence and is in talks with Cano, although health insurance company Humana has a right of first refusal should it seek to do a deal, Bloomberg reported Friday (Oct. 7), citing unnamed sources.

Report: CVS Considering Buying Healthcare Provider Cano

A report says the healthcare conglomerate is discussing an acquisition of primary care chain Cano Health.

CVS in 'Exclusive Talks' to Buy Cano Health: Report

Cano Health, Inc. (CANO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Strength Seen in Cano Health, Inc. (CANO): Can Its 32.2% Jump Turn into More Strength?

Humana

Source: metamorworks / Shutterstock Cano Health (NYSE: CANO ) stock is moving on Friday from reports that Humana (NYSE: HUM ) and CVS (NYSE: CVS ) are considering buying the company. According to insider sources, both companies have expressed interest in buying out CANO and bringing the company into their folds.

CANO Stock Moves as Humana, CVS Consider Acquisition

Humana could be considering buying Cano Health, according to a Wall Street Journal (WSJ) report citing unnamed sources. This comes amid a broader movement of healthcare giants buying out primary-care providers.

News for Cano Health Stock (CANO)